OPTIMIZERx Corp
NASDAQ:OPRX

Watchlist Manager
OPTIMIZERx Corp Logo
OPTIMIZERx Corp
NASDAQ:OPRX
Watchlist
Price: 8.66 USD 3.34% Market Closed
Market Cap: 160.1m USD

Wall Street
Price Targets

OPRX Price Targets Summary
OPTIMIZERx Corp

Wall Street analysts forecast OPRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OPRX is 10.16 USD with a low forecast of 6.06 USD and a high forecast of 16.8 USD.

Lowest
Price Target
6.06 USD
30% Downside
Average
Price Target
10.16 USD
17% Upside
Highest
Price Target
16.8 USD
94% Upside
OPTIMIZERx Corp Competitors:
Price Targets
3902
Medical Data Vision Co Ltd
4% Upside
NXU
Nexus AG
2% Upside
SLP
Simulations Plus Inc
27% Upside
300253
Winning Health Technology Group Co Ltd
4% Upside
ALC
Alcidion Group Ltd
38% Upside
M7T
Mach7 Technologies Ltd
266% Upside
2413
M3 Inc
13% Upside
KSI
Kneat.com Inc
36% Upside

Revenue
Forecast

Revenue Estimate
OPTIMIZERx Corp

For the last 8 years the compound annual growth rate for OPTIMIZERx Corp's revenue is 36%. The projected CAGR for the next 2 years is 11%.

36%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
OPTIMIZERx Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
OPTIMIZERx Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OPRX's stock price target?
Price Target
10.16 USD

According to Wall Street analysts, the average 1-year price target for OPRX is 10.16 USD with a low forecast of 6.06 USD and a high forecast of 16.8 USD.

What is OPTIMIZERx Corp's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for OPTIMIZERx Corp's revenue is 36%. The projected CAGR for the next 2 years is 11%.

Back to Top